Drug details

Orbactiv IV (orbactiv oritavancin injection)

type of Glycopeptides

Orbactiv (oritavancin) for injection is an antibiotic used to treat adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following Gram-positive microorganisms: Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus anginosus group (includes S. anginosus, S. intermedius, and S. constellatus), and Enterococcus faecalis (vancomycin-susceptible isolates only).

This drug may have the following side effects:

• chest pain,
• sweating,
• lightheadedness,
• dizziness,
• itching,
• swelling
• chills,
• pain, and
• rash,
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• severe stomach pain, 
• back pain,
• tremors, 
• warmth, 
• redness in your face or upper body, 
• diarrhea that is watery or bloody (even if it occurs months after), 

The following drugs are related to Orbactiv IV, either as a replacement or used together:

• Avelox (moxifloxacin hcl)
• Zithromax Injection (azithromycin)
• Zithromax (azithromycin)
• Cefzil (cefprozil)
• Ceftin (cefuroxime axetil)
• Zinacef (cefuroxime)
• Levaquin (levofloxacin)
• Zyvox (linezolid)
• Tygacil (tigecycline)
• Trovan - Zithromax (trovafloxacin and azithromycin)
• Vancocin (vancocin)